AHK-Cu (Alanine-Histidine-Lysine Copper) vs Carnosine
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
AHK-Cu (Alanine-Histidine-Lysine Copper)
Copper-chelating tripeptide structurally related to GHK-Cu but optimized for scalp and hair follicle applications. AHK-Cu activates hair follicle stem cells and prolongs the anagen (active growth) phase, making it a key research compound for androgenetic alopecia and diffuse hair loss. Used topically as an alternative or complement to minoxidil and finasteride.
Full profileCarnosine
Naturally occurring dipeptide (β-alanine + L-histidine) found at high concentrations in skeletal muscle and brain. Functions as a pH buffer, anti-glycation agent, antioxidant, and metal chelator. Extensively studied for athletic performance (pH buffering), neuroprotection, anti-aging (AGE formation prevention), and cataract research (eye drops).
Full profile| AHK-Cu (Alanine-Histidine-Lysine Copper) | Carnosine | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | AHK copper peptide, Ala-His-Lys copper, hair growth copper peptide, AHK-copper complex | β-alanyl-L-histidine, L-carnosine, brain dipeptide, muscle dipeptide |
| Evidence | Research-stage | Research-stage |
| Dosing range | 0.1%–1% %, Daily topical application (scalp) | 500mg–2000mg mg, twice daily oral |
| Administration | Topical (scalp serum/solution), Subcutaneous (microneedling-assisted delivery) | Oral (capsule/powder), Topical (eye drops — cataract research) |
| Key side effects | Mild scalp irritation, Contact dermatitis (rare), Temporary scalp redness or tingling, Transient scalp shedding at initiation (shedding phase) | Generally well-tolerated, Mild GI discomfort at high doses (>2g/day), Rare: carnosinemia in carnosinase deficiency (genetic condition), Zinc chelation may reduce zinc availability at very high doses |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: AHK-Cu (Alanine-Histidine-Lysine Copper) — Topical (scalp serum/solution), Subcutaneous (microneedling-assisted delivery); Carnosine — Oral (capsule/powder), Topical (eye drops — cataract research).
- Dosing units differ: AHK-Cu (Alanine-Histidine-Lysine Copper) is dosed in %, Carnosine in mg — they operate at different scales.
- Frequency: AHK-Cu (Alanine-Histidine-Lysine Copper) is typically Daily topical application (scalp); Carnosine is twice daily oral.
How each works
AHK-Cu (Alanine-Histidine-Lysine Copper)
AHK-Cu activates β-catenin/Wnt signaling in dermal papilla cells and promotes VEGF expression around hair follicles. Studies demonstrate extended anagen phase duration, increased follicle size, and upregulation of hair growth factors in treated scalp tissue. The copper component supports tyrosinase activity for follicle pigmentation and metalloenzymes involved in extracellular matrix remodeling around follicles.
Carnosine
Carnosine's multi-mechanism activity explains interest across several research domains. Its histidine moiety buffers intramuscular pH during high-intensity exercise, directly improving performance. As an anti-glycation agent, carnosine quenches reactive carbonyl species that form advanced glycation end-products (AGEs), potentially slowing protein crosslinking associated with tissue aging. Brain carnosine concentrations correlate with cognitive vitality in aging research.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.